Recerca Programes
Recerca, Salut materna, infantil i reproductiva

HIV drug resistance (HIVDR)

Description of HIV drug resistance patterns and its association with the risk of HIV mother to child transmission among pregnant women from southern Mozambique

Durada
01/01/2023 - 31/12/2025
Coordinador
Raquel González
Finançadors
Instituto de Salud Carlos III

HIV drug resistance (HIVDR) can compromise the effectiveness of antiretroviral therapy (ART), which is particularly important among pregnant women from sub-Saharan Africa due to the high burden of infection in the region and the risk of HIV mother to child transmission (MTCT).

Objective

To describe the prevalence and characteristics of HIVDR mutations among Mozambican pregnant women before and after dolutegravir (DTG) scale up in the country, and to evaluate its association with the risk of MTCT of HIV through breastfeeding.

Methods

Plasma samples from 200 HIV-infected pregnant women with virological failure (HIV viral load> 50 c/ml) will be analyzed. HIVDR will be determined using MiSeq® in samples collected at the first antenatal care visit and at delivery. In a sub-sample of participants, the presence of HIV in breastmilk will also be analyzed.

Total Funding

123,000 EUR

 

 

Our Team

Coordinator

ISGlobal Team

Altres projectes

Veure projectes passats

CaDMIA-plus

Validación continuada de la autopsia mínimamente invasiva (MIA) para la investigación de la causa de muerte en niños pequeños, y desarrollo de un centro de investigación y formación sobre el estudio de la causa de muerte

ICARIA

Improving Care through Azithromycin Research for Infants in Africa

MIBio

Identification of Prematurity and Pre-Eclampsia as Causes of Mortality

MULTIPLY

MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention

MA-CoV

Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations

IPERVAC-SL

Impact of perceptions of COVID-19 vaccines on health-seeking behaviours in Sierra Leone

RESPIRE

Respiratory syncytial virus (RSV) in African pregnant women and children

VITAL

Towards preparedness for new maternal vaccinations: Understanding barriers and facilitators to maternal vaccine acceptance